Nurix Therapeutics (NRIX) Receivables - Other (2020 - 2025)
Historic Receivables - Other for Nurix Therapeutics (NRIX) over the last 6 years, with Q4 2025 value amounting to $1.5 million.
- Nurix Therapeutics' Receivables - Other changed 0.0% to $1.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $1.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.5 million for FY2025, which is 0.0% changed from last year.
- Nurix Therapeutics' Receivables - Other amounted to $1.5 million in Q4 2025, which was down 0.0% from $1.7 million recorded in Q3 2025.
- Nurix Therapeutics' 5-year Receivables - Other high stood at $7.0 million for Q1 2025, and its period low was $600000.0 during Q2 2024.
- Over the past 5 years, Nurix Therapeutics' median Receivables - Other value was $1.7 million (recorded in 2025), while the average stood at $2.5 million.
- Per our database at Business Quant, Nurix Therapeutics' Receivables - Other tumbled by 8800.0% in 2021 and then surged by 30000.0% in 2023.
- Quarter analysis of 5 years shows Nurix Therapeutics' Receivables - Other stood at $900000.0 in 2021, then increased by 11.11% to $1.0 million in 2022, then soared by 300.0% to $4.0 million in 2023, then plummeted by 62.5% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025.
- Its Receivables - Other stands at $1.5 million for Q4 2025, versus $1.7 million for Q3 2025 and $1.7 million for Q2 2025.